Healthcare
Live Price
Offline$15.59
+4.21% today
1Y Change
+5.16%
Window
Jun 26, 2025 → Jun 22, 2026
Coverage: 247 bars · Jun 26, 2025 → Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Biohaven Ltd. (BHVN) is a Healthcare stock with a market cap of $1.03B. The stock last traded around $15.59 and up 5.2% across the available one-year price window (Jun 26, 2025 → Jun 22, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +26.1%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +26.1%, free cash flow -4.0% with operating margin 0.0% and ROIC -157.9%. Stock Foundry combines BHVN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BHVN
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BHVN Max Drawdown
-56.99%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BHVN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$213.8M
+62.5% YoY
Free Cash Flow
-$146.8M
+56.7% YoY
Revenue Growth
+0.0%
EPS Growth
+26.1%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -4M | 0 | 0 | 0 | 0 |
| Operating Income | -745M | -885M | -436M | -568M | -219M |
| EBITDA | -727M | -877M | -429M | -567M | -218M |
| Net Income | -739M | -846M | -408M | -570M | -214M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 230M | 99M | 248M | 205M | 76M |
| Total Assets | 451M | 615M | 513M | 662M | 142M |
| Total Liabilities | 399M | 192M | 85M | 123M | 47M |
| Shareholder Equity | 52M | 423M | 428M | 539M | 35M |
| Total Debt | 279M | 37M | 31M | 34M | 3M |
| Net Debt | 49M | -63M | -218M | -171M | -73M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
146M
+51.0% YoY
Capital Expenditures
938K
+97.7% YoY
Free Cash Flow
147M
+56.7% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-866.5%
Debt / Equity
2.16x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.